MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT02422381 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02422381
Sponsor: Providence Health & Services
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2015-07-20
Primary completion: 2019-01-09
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.